671
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia

&
Pages 4589-4597 | Published online: 26 Nov 2020

References

  • World health organization. Global Report on Diabetes. Geneva; 2016.
  • International Diabetes Federation. IDF Diabetes Atlas Ninth Edition 2019. 2019.
  • Zheng Y, Ley SH, Hu FB. Global etiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017;14(2):88–98.
  • Chaudhury D, Aggarwal A. Diabetic dyslipidemia: current concepts in pathophysiology and management. J Clin Diagn Res. 2018;12(1):10–13.
  • Kalofoutis C, Piperi C, Kalofoutis A, Harris F. Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Exp Clin Cardiol. 2007;12(1):17–28.
  • Abdosh T, Weldegebreal F. Cardiovascular diseases risk factors among adult diabetic patients in eastern Ethiopia. JRSM Cardiovasc Dis. 2019;8:1–7.
  • Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771–782.
  • Ambachew H, Shimelis T, Lemma K. Dyslipidemia among diabetic patients in Southern Ethiopia. J Diabetes Endocrinol. 2015;6(4):19–24. doi:10.5897/JDE2015.0086
  • Daya R, Bayat Z, Raal FJ. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients at a tertiary care hospital. J Endocrinol Metab Diabetes S Af. 2017;22(3):31–35. doi:10.1080/16089677.2017.1360064
  • Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clin Lipidol. 2011;6(4):401–411. doi:10.2217/clp.11.32
  • Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism. 2014;63(12):1469–1479. doi:10.1016/j.metabol.2014.08.010
  • Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):1–12. doi:10.5551/jat.RV17023
  • Schofield JD, Liu Y, Rayaz PR, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Ther. 2016;7(2):203–219. doi:10.1007/s13300-016-0167-x
  • Goldberg IRAJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–971. doi:10.1210/jcem.86.3.7304
  • Salim A, Ghouth B, Ba-karman AA, Alaidroos HA, Alajely MH. Prevalence and patterns of dyslipidemia among type 2 diabetes mellitus patients in Mukalla City, Yemen, in 2017. J Community Med Public Health. 2019;6:6–11.
  • Kiplagat SV, Lydia K, Jemimah K, Drusilla M. Prevalence of dyslipidemia, and the associated factors among type 2 diabetes patients in Turbo Sub-county, Kenya. J Endocrinol Diabetes. 2017;4(5):1–9. doi:10.15226/2374-6890/4/5/00190
  • Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids Health Dis. 2019;1–8.
  • Abdel-aal NM, Ahmad AT, Froelicher ES, Hamza MM, Ajlouni KM. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan. Saudi Med J. 2008;29(10):1423–1428.
  • Shiferaw B, Tagesech Y, Abdurrahman E. Dyslipidemia and associated factors among diabetic patients attending durame general hospital in southern nations, nationalities, and people’s region. Diabetes Metab Syndr Obes. 2017;10:265–271. doi:10.2147/DMSO.S135064
  • Solomon T, Fessaye A. Cardiovascular disease among diabetic patients in southwest Ethiopia. Ethiop J Health Sci. 2010;20:122–128.
  • Abera MA, Gebregziabher T, Tesfay H, Alemayehu M. Factors associated with the occurrence of hypertension and dyslipidemia among diabetic patients attending the diabetes clinic of Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia. East Afr J Health Sci. 2019;1(1):1–14.
  • Pokharel DR, Khadka D, Sigdel M, et al. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. BMC Res Notes. 2017;1–11.
  • Bello-ovosi BO, Ovosi JO, Ogunsina MA, Asuke S, Ibrahim MS. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria. Pan Afr Med J. 2019;8688:1–10.
  • Chamba NG, Shao ER, Sonda T, Lyarru IA. Lipid profile of type 2 diabetic patients at a tertiary hospital in tanzania: cross-sectional study. J Endocrinol Diabetes. 2017;4:1–6.
  • Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in China. Int J Environ Res Public Health. 2015;60(10):13455–13465. doi:10.3390/ijerph121013455
  • Gebreyes YF, Goshu DY, Geletew TK, et al. Prevalence of high blood pressure, hyperglycemia, dyslipidemia, metabolic syndrome, and their determinants in Ethiopia: evidence from the national NCDs STEPS survey. PLoS One. 2015;13(5):1–18.
  • Dhoj TS, Raj KCS, Santosh G, Deepika G. Dyslipidemia in type 2 diabetes mellitus. J Pathol Nepal. 2017;7(2):1149–1154. doi:10.3126/jpn.v7i2.17978
  • Waly EH, Hamed MS. Hypertension and dyslipidemia among type ii diabetic patients and related risk factors and complications. Egypt J Commun Med. 2018;36(1):31–43.
  • Belete B, Biadgo B, Abebe SM, et al. Correlation between serum lipid profile with anthropometric and clinical variables in patients with type 2 diabetes mellitus. Ethiop J Health Sci. 2017;27(3):215–226. doi:10.4314/ejhs.v27i3.3
  • Dixit AK, Panda AK, Mitra A. The prevalence of dyslipidemia in patients with diabetes mellitus of Ayurveda Hospital. J Diabetes Metab Disord. 2014;1–6.
  • Mandal M, Kumari R, Mukherjee A. Prevalence of dyslipidemia in patients with type 2 diabetes mellitus: a hospital-based study in Kishanganj, India. Int J Res Med Sci. 2015;3(12):3691–3697. doi:10.18203/2320-6012.ijrms20151424